Extract from the Register of European Patents

EP About this file: EP1754478

EP1754478 - Liquid Composition comprising arginine and alpha-lipoic acid and its use for improvement of sexual function [Right-click to bookmark this link]
Former [2007/08]Solid Composition comprising a NO donor and a Dithiolane and its use for improvement of sexual function
[2008/20]
StatusNo opposition filed within time limit
Status updated on  06.11.2009
Database last updated on 28.03.2026
Most recent event   Tooltip06.11.2009No opposition filed within time limitpublished on 09.12.2009  [2009/50]
Applicant(s)For all designated states
Encrypta GmbH
Stichelfeldstrasse 3
61350 Bad Homburg vor der Höhe / DE
[N/P]
Former [2009/17]For all designated states
Encrypta Gmbh
Stichelfeldstrasse 3
61350 Bad Homburg vor der Höhe / DE
Former [2007/08]For all designated states
Extarma AG
Sihlporte 3
8001 Zürich / CH
Inventor(s)01 / Wessel, Klaus
Hinter der Mauer 108
61118 Bad Vilbel / DE
 [2007/08]
Representative(s)Fuchs Patentanwälte Partnerschaft mbB
Postfach 46 60
65036 Wiesbaden / DE
[N/P]
Former [2008/28]Fuchs
Patentanwälte Postfach 46 60
65036 Wiesbaden / DE
Former [2007/27]Fuchs Mehler Weiss & Fritzsche
Patentanwälte Postfach 46 60
65036 Wiesbaden / DE
Former [2007/08]KEIL & SCHAAFHAUSEN Patentanwälte
Cronstettenstrasse 66
60322 Frankfurt am Main / DE
Application number, filing date05107206.404.08.2005
[2007/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1754478
Date:21.02.2007
Language:EN
[2007/08]
Type: B1 Patent specification 
No.:EP1754478
Date:31.12.2008
Language:EN
[2009/01]
Search report(s)(Supplementary) European search report - dispatched on:EP17.01.2006
ClassificationIPC:A61K31/198, A61K31/385, A61P15/10, A61P15/12, A61P15/00
[2007/08]
CPC:
A61K31/198 (EP,US); A61K31/385 (EP,US); A61P15/00 (EP);
A61P15/08 (EP); A61P15/10 (EP); A61P15/12 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/08]
Extension statesAL10.08.2007
BA10.08.2007
HR10.08.2007
MK10.08.2007
TitleGerman:Flüssige Zusammensetzung enthaltend Arginine und alpha-Liponsäure zur Verbesserung der sexuellen Funktion[2008/20]
English:Liquid Composition comprising arginine and alpha-lipoic acid and its use for improvement of sexual function[2008/20]
French:Formulation liquide contenant de l'arginine et de l'acide lipoïde alpha pour améliorer la fonction sexuelle[2008/20]
Former [2007/08]Feste Zusammensetzung enthaltend einen NO Donor und einen Ditholan zur Verbesserung der sexuellen Funktion
Former [2007/08]Solid Composition comprising a NO donor and a Dithiolane and its use for improvement of sexual function
Former [2007/08]Formulation solide contenant un donneur d'oxyde nitrique (no) et un ditholane pour améliorer la fonction sexuelle
Examination procedure04.07.2006Amendment by applicant (claims and/or description)
04.07.2006Examination requested  [2007/08]
12.10.2006Despatch of a communication from the examining division (Time limit: M06)
23.04.2007Reply to a communication from the examining division
06.07.2007Despatch of a communication from the examining division (Time limit: M04)
05.10.2007Reply to a communication from the examining division
17.12.2007Despatch of a communication from the examining division (Time limit: M04)
07.02.2008Reply to a communication from the examining division
18.07.2008Communication of intention to grant the patent
13.11.2008Fee for grant paid
13.11.2008Fee for publishing/printing paid
Opposition(s)01.10.2009No opposition filed within time limit [2009/50]
Fees paidRenewal fee
23.06.2007Renewal fee patent year 03
13.08.2008Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipRO31.12.2008
[2009/45]
Documents cited:Search[DXY] DE3840076  (ASTA PHARMA AG et al.)
 [DX] WO03032751  (FASSI ALDO et al.)
 [DY] WO03028714  (DE SIMONE CLAUDIO et al.)
 [DY] WO0219999  (SACKS MEIR S et al.)
 [Y]   BIEWENGA G P ET AL: "THE PHARMACOLOGY OF THE ANTIOXIDANT LIPOIC ACID", GENERAL PHARMACOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 29, no. 3, 1997, pages 315 - 331, XP001096077, ISSN: 0306-3623

DOI:   http://dx.doi.org/10.1016/S0306-3623(96)00474-0
by applicantDE4035442
 US6387945
 EP0089126
 US6605637
 US2004019084
 WO03028714
 WO0059448
 WO03032751
 EP1273295
 EP0947194
 DE3840076
 US5281722
 DE4317646
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.